Accession | Title | Series type(s) | Organism(s) | Samples | GDS | Supplementary | Contact | Release date |
---|---|---|---|---|---|---|---|---|
Filter | Expression profiling by high throughput sequencing | GCT | Roland Schmucki | |||||
GSE86001 |
Binding to SMN2 pre-mRNA-Protein complex elicits specificity for small molecule splicing modifiers
|
|
6 |
|
Roland Schmucki | Aug 11, 2017 | ||
GSE101575 |
RNA-seq of HBV-infected differentiated HepaRG under RG7834
|
|
24 |
|
Roland Schmucki | Oct 18, 2017 | ||
GSE94111 |
Rational targeting of RNA structure in SMN2 transcripts reverses Spinal Muscular Atrophy molecular phenotypes
|
|
8 |
|
Roland Schmucki | Mar 06, 2018 | ||
GSE92346 |
Expression charcaterization of an internal protocol developed to differentiate RPE cells
|
|
40 |
|
Roland Schmucki | Jun 20, 2018 | ||
GSE110137 |
Mode of action characterization of antibiotics using expression profile fingerprints generated by RNA-sequencing technology
|
|
57 |
|
Roland Schmucki | Mar 25, 2019 | ||
GSE159108 |
Generation and characterization of human iPSC-derived microglia-like cells for the use in drug discovery
|
|
20 |
|
Roland Schmucki | Feb 24, 2021 | ||
GSE169252 |
CD22 blockage restores age-related impairments of microglia surveillance capacity
|
|
16 |
|
Roland Schmucki | Mar 30, 2021 | ||
GSE246666 |
Selective oxytocin receptor activation prevents prefrontal circuit dysfunction and social behavioral alterations in response to chronic prefrontal cortex activation in rats
|
|
12 | Roland Schmucki | Nov 05, 2023 | |||
GSE276803 |
Fenebrutinib, a Bruton’s tyrosine kinase inhibitor, blocks distinct human microglial signaling pathways
|
|
23 | Roland Schmucki | Oct 28, 2024 |